Neutral
Johnson & Johnson's stock remains steady at $267.28 amid recent developments.
Over the past 24 hours, Johnson & Johnson's stock price has remained relatively unchanged, closing at $267.28 on September 16, 2026. This stability comes despite recent developments, including a Pennsylvania jury finding the company liable in a talc-related cancer case. The company has indicated plans to appeal the verdict.
Key points
- Johnson & Johnson's stock price remains steady at $267.28.
- A Pennsylvania jury found Johnson & Johnson liable in a talc-related cancer case.
- The company plans to appeal the recent court verdict.
Sources
- Pennsylvania jury finds Johnson & Johnson liable for cancer in latest talc trialReuters · February 13, 2026
- Johnson & Johnson's Stock Price at Critical Turning PointMarketBeat · January 24, 2024
- Johnson & Johnson stock drops following dismissal of bankruptcy strategy tied to talc lawsuitsYahoo Finance · January 30, 2023
AI-generated from public news sources. Not financial advice.
